4//SEC Filing
McAvoy David R. 4
Accession 0000950170-25-035533
CIK 0000818686other
Filed
Mar 6, 7:00 PM ET
Accepted
Mar 7, 4:22 PM ET
Size
5.9 KB
Accession
0000950170-25-035533
Insider Transaction Report
Form 4
McAvoy David R.
EVP, Chief Legal Officer
Transactions
- Award
Restricted Share Units
2025-03-05+56,603→ 56,603 total→ Ordinary Shares (56,603 underlying)
Footnotes (3)
- [F1]Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share.
- [F2]Restricted share units were granted on March 5, 2025, with 14,150 vesting on each of March 5, 2026, March 5, 2027 and March 5, 2028, and 14,153 vesting on March 5, 2029.
- [F3]The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
Documents
Issuer
TEVA PHARMACEUTICAL INDUSTRIES LTD
CIK 0000818686
Entity typeother
Related Parties
1- filerCIK 0001758842
Filing Metadata
- Form type
- 4
- Filed
- Mar 6, 7:00 PM ET
- Accepted
- Mar 7, 4:22 PM ET
- Size
- 5.9 KB